The LNS Direction is composed of the Director ad interim, Pr Dr André Rosenthal, a Chief Financial and Administrative Officer (CFAO), Safaâ Moujahid, and a Chief Operating Officer (COO), Dr Thomas Dentzer.
Prof. Dr. André Rosenthal, Director ad interim
Prof. Dr. André Rosenthal is the director ad interim of the Laboratoire national de santé (LNS) until a new director is appointed.
With a scientific background in molecular biology, human and molecular genetics and translational oncology, André Rosenthal was a key member of the International Human Genome Project. He headed the German human genome sequencing program. His team at the Institute of Molecular Biotechnology (IMB) at Friedrich Schiller University in Jena, Germany, was responsible for the sequencing of chromosome 21 and significant parts of the human X chromosome.
As an entrepreneur, André Rosenthal founded Signature Diagnostics, a cancer diagnostic company in Germany today owned by Roche. Within Signature and Roche Diagnostics he worked on next generation sequencing (NGS) assays for circulating tumor DNA and its use for minimal residual disease detection in early stage colorectal cancer and monitoring patients with advanced NSCLC (Non-Small Cell Lung Cancer) and SCLC (Small Cell Lung Cancer). His work supported the development of the AVENIO ctDNA kit. André Rosenthal is also the CEO and co-founder of Fertiga, a Belgian company in the field of female fertility that developed a gene test for oocyte quality, and the President and co-founder of Lavima Fertility, an American company active in the development of new technologies for the in vitro maturation of oocytes.
André Rosenthal is the author and co-author of over 140 articles and the inventor of over 30 patents.
Safaâ Moujahid, Chief Financial and Administrative Officer
Safaâ Moujahid holds a degree in Biotechnology from Polytech Marseille and a diploma in Management and Strategy from KEDGE Business School. She previously worked for PwC, Deloitte and KPMG in Luxembourg as a consultant in the healthcare and public sectors.
As part of her assignments, Safaâ Moujahid worked on the development, structuring and implementation of strategic projects in Luxembourg. During the pandemic, Safaâ Moujahid was responsible for coordinating nationwide projects on behalf of the Health Directorate, such as managing the procurement of vaccines and medicines against COVID-19 in collaboration with the European Health Emergency Response and Preparedness Authority (HERA), and the Large Scale Testing programme.
Most recently, she was a director at PwC Switzerland, where she worked as an external consultant for one of the United Nations agencies on the definition of a global framework to strengthen the preparedness, response and resilience of health systems in the face of health emergencies.
In her role at LNS, Safaâ Moujahid is responsible for all financial and administrative aspects of LNS. In particular, she oversees the finance and purchasing department, human resources, risk management, legal affairs and the LNS’s infrastructure and logistics. She ensures that processes are optimised and that the resources allocated to the public institution are managed efficiently.
Dr Thomas Dentzer, Chief Operation Officer
A graduate of The Rockefeller University in New York (PhD in virology) and Albert-Ludwigs-Universität Freiburg im Breisgau in Germany (Master’s degree in biology), Dr Thomas Dentzer has extensive experience and expertise in the field of public health in Luxembourg.
Before joining LNS, he successively held the positions of postdoctoral researcher at the Luxembourg Institute of Health (LIH), consultant for Deloitte developing Healthcare & Life Sciences activities, head of the Life Sciences sector at the national innovation agency (Luxinnovation) in Luxembourg and at the same time director of the Luxembourg BioHealth Cluster. He has also worked for the Directorate of Health, where he was in charge of coordination, strategic development, digital health and international relations, and as a lecturer at the University of Luxembourg. During the pandemic, he was also responsible for national screening strategies.
At LNS, Thomas Dentzer is now in charge of operations, coordinating and supporting the main business processes of the departments making up the multi-disciplinary institute, with a focus on efficiency and performance. His remit also includes quality and IT. He encourages the implementation of digital approaches to improve both operational robustness and efficiency, while fostering a ‘digital culture’ and data-driven approach within LNS.
In addition to his activities at LNS, Thomas Dentzer is also active in organisations in the healthcare sector. In particular, he is co-leader of the National Task Force on Digital Health for Healthcare Transformation and a board member of the European Centre for Disease Prevention and Control (ECDC), the European Health Emergency Response and Preparedness Authority (HERA) and the Standing Committee of the WHO Europe Regional Committee (SCRC).